Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02000232 · ClinicalTrials.gov registry record
Impact of Unapproved Drug Initiative on Colchicine Use
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 185
- Enrollment target
NCT02000232: Completed study, sponsored by Stanford University.
NCT02000232 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 185 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02000232 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 185 participants
- Enrollment target
Study Summary
Measure if FDA regulation of Colchicne in 2009 has resulted in safer use in clinical settings. Our study will assess the impact of this Initiative on colchicine use and will provide data that supports its continuation and expansion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02000232
The ClinicalTrials.gov registry entry for NCT02000232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02000232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02000232 about?
NCT02000232 is a clinical study titled "Impact of Unapproved Drug Initiative on Colchicine Use". Measure if FDA regulation of Colchicne in 2009 has resulted in safer use in clinical settings. Our study will assess the impact of this Initiative on colchicine use and will provide data that supports its continuation and expansion.
What is the current status of trial NCT02000232?
This trial is currently completed. The enrollment target is 185 participants. The study started on 2013-01. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT02000232?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.